Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatostatin for Post Hepatectomy Liver Failure
NCT02882347Phase 3Unknown
- Sponsor
- Korea University Anam Hospital
- Start
- Jul 2015
- Primary completion
- Jul 2017
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of somatostatin in post-hepatectomy liver failure (PHLF), sponsored by Korea University Anam Hospital. Status: unknown.
02
Drugs
somatostatin
03
Conditions
post-hepatectomy liver failure (PHLF)
Beyond the preview
Go deeper on NCT02882347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02882347.